TNFα increases hypothalamic PTP1B activity via the NFκB pathway in rat hypothalamic organotypic cultures

Regulatory Peptides

Volumn 174, Issue 1-3, 2012, Pages 58-64

  Ito, Yoshihiro ^a   Banno, Ryoichi ^a   Hagimoto, Shigeru ^a   Ozawa, Yoshiharu ^a   Arima, Hiroshi ^a   Oiso, Yutaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

NF B; PTP1B; TNF

Indexed keywords

I KAPPA B; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE 1B; TETRODOTOXIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ACTION POTENTIAL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; CYTOKINE RESPONSE; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; ENZYME REPRESSION; HYPOTHALAMUS; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TISSUE CULTURE;

ANIMALS; HYPOTHALAMUS; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84856431865     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.11.010     Document Type: Article

References (48)

1. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443:289-295.
2. Schwartz M.W., Woods S.C., Porte D., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature 2000, 404:661-671.
3. Riccardi G., Giacco R., Rivellese A.A. Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23:447-456.
4. Ahmad F., Li P.M., Meyerovitch J., Goldstein B.J. Osmotic loading of neutralizing antibodies demonstrates a role for protein-tyrosine phosphatase 1B in negative regulation of the insulin action pathway. J Biol Chem 1995, 270:20503-20508.
5. Tiganis T., Bennett A.M. Protein tyrosine phosphatase function: the substrate perspective. Biochem J 2007, 402:1-15.
6. White C.L., Whittington A., Barnes M.J., Wang Z., Bray G.A., Morrison C.D. HF diets increase hypothalamic PTP1B and induce leptin resistance through both leptin-dependent and -independent mechanisms. Am J Physiol Endocrinol Metab 2009, 296:E291-E299.
7. Picardi P.K., Caricilli A.M., de Abreu L.L., Carvalheira J.B., Velloso L.A., Saad M.J. Modulation of hypothalamic PTP1B in the TNF-alpha-induced insulin and leptin resistance. FEBS Lett 2010, 584:3179-3184.
8. Elchebly M., Payette P., Michaliszyn E., Cromlish W., Collins S., Loy A.L., Normandin D., Cheng A., Himms-Hagen J., Chan C.C., Ramachandran C., Gresser M.J., Tremblay M.L., Kennedy B.P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999, 283:1544-1548.
9. Klaman L.D., Boss O., Peroni O.D., Kim J.K., Martino J.L., Zabolotny J.M., Moghal N., Lubkin M., Kim Y.B., Sharpe A.H., Stricker-Krongrad A., Shulman G.I., Neel B.G., Kahn B.B. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000, 20:5479-5489.
10. Bence K.K., Delibegovic M., Xue B., Gorgun C.Z., Hotamisligil G.S., Neel B.G., Kahn B.B. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 2006, 12:917-924.
11. Banno R., Zimmer D., De Jonghe B.C., Atienza M., Rak K., Yang W., Bence K.K. PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest 2010, 120:720-734.
12. De Souza C.T., Araujo E.P., Bordin S., Ashimine R., Zollner R.L., Boschero A.C., Saad M.J., Velloso L.A. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-4199.
13. Milanski M., Degasperi G., Coope A., Morari J., Denis R., Cintra D.E., Tsukumo D.M., Anhe G., Amaral M.E., Takahashi H.K., Curi R., Oliveira H.C., Carvalheira J.B., Bordin S., Saad M.J., Velloso L.A. Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2006, 29:359-370.
14. Posey K.A., Clegg D.J., Printz R.L., Byun J., Morton G.J., Vivekanandan-Giri A., Pennathur S., Baskin D.G., Heinecke J.W., Woods S.C., Schwartz M.W., Niswender K.D. Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 2009, 296:E1003-E1012.
15. Zhang X., Zhang G., Zhang H., Karin M., Bai H., Cai D. Hypothalamic IKKbeta/NF-kappaB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008, 135:61-73.
16. Kleinridders A., Schenten D., Konner A.C., Belgardt B.F., Mauer J., Okamura T., Wunderlich F.T., Medzhitov R., Bruning J.C. MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009, 10:249-259.
17. Coppack S.W. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001, 60:349-356.
18. Katsuki A., Sumida Y., Murashima S., Murata K., Takarada Y., Ito K., Fujii M., Tsuchihashi K., Goto H., Nakatani K., Yano Y. Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1998, 83:859-862.
19. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
20. Winkler G., Salamon F., Salamon D., Speer G., Simon K., Cseh K. Elevated serum tumour necrosis factor-alpha levels can contribute to the insulin resistance in Type II (non-insulin-dependent) diabetes and in obesity. Diabetologia 1998, 41:860-861.
21. Zabolotny J.M., Kim Y.B., Welsh L.A., Kershaw E.E., Neel B.G., Kahn B.B. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem 2008, 283:14230-14241.
22. Arima H., House S.B., Gainer H., Aguilera G. Neuronal activity is required for the circadian rhythm of vasopressin gene transcription in the suprachiasmatic nucleus in vitro. Endocrinology 2002, 143:4165-4171.
23. Kuwahara S., Arima H., Banno R., Sato I., Kondo N., Oiso Y. Regulation of vasopressin gene expression by cAMP and glucocorticoids in parvocellular neurons of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neurosci 2003, 23:10231-10237.
24. Sato I., Arima H., Ozaki N., Watanabe M., Goto M., Hayashi M., Banno R., Nagasaki H., Oiso Y. Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems. J Neurosci 2005, 25:8657-8664.
25. Wray S., Kusano K., Gainer H. Maintenance of LHRH and oxytocin neurons in slice explants cultured in serum-free media: effects of tetrodotoxin on gene expression. Neuroendocrinology 1991, 54:327-339.
26. Cho H., Krishnaraj R., Itoh M., Kitas E., Bannwarth W., Saito H., Walsh C.T. Substrate specificities of catalytic fragments of protein tyrosine phosphatases (HPTP beta, LAR, and CD45) toward phosphotyrosylpeptide substrates and thiophosphotyrosylated peptides as inhibitors. Protein Sci 1993, 2:977-984.
27. Arima H., House S.B., Gainer H., Aguilera G. Direct stimulation of arginine vasopressin gene transcription by cAMP in parvocellular neurons of the paraventricular nucleus in organotypic cultures. Endocrinology 2001, 142:5027-5030.
28. Goto M., Arima H., Watanabe M., Hayashi M., Banno R., Sato I., Nagasaki H., Oiso Y. Ghrelin increases neuropeptide Y and agouti-related peptide gene expression in the arcuate nucleus in rat hypothalamic organotypic cultures. Endocrinology 2006, 147:5102-5109.
29. Shimizu H., Arima H., Watanabe M., Goto M., Banno R., Sato I., Ozaki N., Nagasaki H., Oiso Y. Glucocorticoids increase neuropeptide Y and agouti-related peptide gene expression via adenosine monophosphate-activated protein kinase signaling in the arcuate nucleus of rats. Endocrinology 2008, 149:4544-4553.
30. Dadke S.S., Li H.C., Kusari A.B., Begum N., Kusari J. Elevated expression and activity of protein-tyrosine phosphatase 1B in skeletal muscle of insulin -resistant type II diabetic Goto-Kakizaki rats. Biochem Biophys Res Commun 2000, 274:583-589.
31. Taghibiglou C., Rashid-Kolvear F., Van Iderstine S.C., Le-Tien H., Fantus I.G., Lewis G.F., Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 2002, 277:793-803.
32. Wu Y., Ouyang J.P., Wu K., Wang S.S., Wen C.Y., Xia Z.Y. Rosiglitazone ameliorates abnormal expression and activity of protein tyrosine phosphatase 1B in the skeletal muscle of fat-fed, streptozotocin-treated diabetic rats. Br J Pharmacol 2005, 146:234-243.
33. Wu Y., Ou-Yang J.P., Wu K., Wang Y., Zhou Y.F., Wen C.Y. Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B. Acta Pharmacol Sin 2005, 26:345-352.
34. Ahmad F., Goldstein B.J. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases. J Cell Biochem 1997, 64:117-127.
35. Nieto-Vazquez I., Fernandez-Veledo S., de Alvaro C., Rondinone C.M., Valverde A.M., Lorenzo M. Protein-tyrosine phosphatase 1B-deficient myocytes show increased insulin sensitivity and protection against tumor necrosis factor-alpha-induced insulin resistance. Diabetes 2007, 56:404-413.
36. Vlantis K., Pasparakis M. Role of TNF in pathologies induced by nuclear factor kappaB deficiency. Curr Dir Autoimmun 2010, 11:80-93.
37. Kracht M., Saklatvala J. Transcriptional and post-transcriptional control of gene expression in inflammation. Cytokine 2002, 20:91-106.
38. Cai D. NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle 2009, 8:2542-2548.
39. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat Rev Immunol 2008, 8:837-848.
40. Perkins N.D., Gilmore T.D. Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 2006, 13:759-772.
41. Takada Y., Singh S., Aggarwal B.B. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. J Biol Chem 2004, 279:15096-15104.
42. McDade T.P., Perugini R.A., Vittimberga F.J., Carrigan R.C., Callery M.P. Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells. J Surg Res 1999, 83:56-61.
43. Wang X., Chen D.G. Recombinant murine cytomegalovirus vector activates human monocyte-derived dendritic cells in a NF-kappaB dependent pathway. Mol Immunol 2009, 46:3462-3465.
44. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396:77-80.
45. Pan W., Kastin A.J. Tumor necrosis factor and stroke: role of the blood-brain barrier. Prog Neurobiol 2007, 83:363-374.
46. Arruda A.P., Milanski M., Coope A., Torsoni A.S., Ropelle E., Carvalho D.P., Carvalheira J.B., Velloso L.A. Low-grade hypothalamic inflammation leads to defective thermogenesis, insulin resistance, and impaired insulin secretion. Endocrinology 2011, 152:1314-1326.
47. Romanatto T., Cesquini M., Amaral M.E., Roman E.A., Moraes J.C., Torsoni M.A., Cruz-Neto A.P., Velloso L.A. TNF-alpha acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient-effects on leptin and insulin signaling pathways. Peptides 2007, 28:1050-1058.
48. Marino J.S., Xu Y., Hill J.W. Central insulin and leptin-mediated autonomic control of glucose homeostasis. Trends Endocrinol Metab 2011, 22:275-285.